Genzyme’s once-daily, oral AUBAGIO® approved in Australia for treatment of relapsing multiple sclerosis Genzyme, 21 Nov 2012 Accessed on 26 Nov 2012 from http://www.businesswire.com/news/genzyme/20121121005881/en. CommentRecommendBookmarkWatch